Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

However, treatment resistance in urological tumors cannot be ignored, which could profoundly impact patient survival and prognosis. The complexity of urological tumors necessitates diverse therapeutic ...

Purpose An original and a revised vancomycin dosing protocol for obese patients were compared with respect to attainment of target serum trough vancomycin concentrations and the occurrence of ...

Theriva Biologics and the Universitat Autònoma de Barcelona to receive a total of €2.28 Million to support the THERICEL ...

One of these patients, who had received two prior lines of PD-1 inhibitor-based therapy and had progressed on their latest treatment of ... inhibitor refractory and resistant patients with melanoma.

After hours: September 20 at 5:05 PM EDT ...

"The risk in emerging mutations is the possibility of transmitting these new resistant variants to the general population with fewer viable treatment options available," said the study's co-senior ...

Kristy Alpert is a freelance travel writer with bylines in Esquire, Travel + Leisure, Cosmopolitan, Men’s Health, Food & Wine, AFAR, Fodor’s Travel, and more. She has visited 86 countries—on ...